Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
12,861,202
-
Share change
-
-23,165
-
Total reported value
-
$72,020,801
-
Put/Call ratio
-
1.5%
-
Price per share
-
$5.60
-
Number of holders
-
62
-
Value change
-
-$50,844
-
Number of buys
-
21
-
Number of sells
-
27
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2016
As of 30 Jun 2016,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,861,202 shares.
The largest 10 holders included
Wildcat Capital Management, LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, NORTHERN TRUST CORP, FRANKLIN RESOURCES INC, and SABBY MANAGEMENT, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.